Antidepressants exposure during gestation and their impact on the neurodevelopment and physical outcomes in the off spring

https://doi.org/10.53730/ijhs.v6nS3.7209

Authors

  • Pallavi Singh Research Scholar, Department of Pharmacy Practice, Vels Institute of Sciences and Technology, Chennai, Pallavaram
  • P. Geetha Assistant Professor, Department of Pharmacy Practice, Vels Institute of Sciences and Technology, Chennai, Pallavaram

Keywords:

antidepressants, estation, neurodevelopment, physical outcomes, off spring

Abstract

This study is aimed to study the gestational exposure to antidepressants and their impact on the neurodevelopment and physical outcomes in the offspring. The objective of the study is to General and medical information, as well as estimations of the level of mental distress will be obtained by standardized questionnaires. To accesses the prevalence of antidepressant associated symptoms in new born Assessment of  Neurodevelopment and physical outcomes of child by using standardized questionnaires namely Early Motor Questionnaire (EMQ) for age group of children from 1-6 years which is parent questionnaire were circulated to control (n-150) and case (n-150). Physical outcomes like congenital malformations, birth weight, seizures, hospitalization, preterm delivery, respiratory distress of children were collected from retrospective data maintained during gestational period and child birth which were collected from clinic. In pregnant women baseline risk of congenital malformations is about 3%, and of cardiovascular malformations, 1%. Rates of spontaneous abortion vary in general population between 15 and 20%. Pre-term births occur in approximately 13% of pregnancies, we found relation between exposure of prenatal antidepressants and  occurrence of physical outcomes like low birth weight, miscarriages, hospitalization, preterm births, respiratory distress, seizures, gastrointestinal problems, improper. 

Downloads

Download data is not yet available.

References

World Health Organization (2012) Depression: A Global public health concern.

Department of Mental Health and Substance Abuse, WHO

The WHO Global Health Estimates (GHE) (2000-2012) Health statistics and information systems.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®) American Psychiatric Pub.

Al-Harbi K (2012) Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Preference and Adherence 6: 369-388

Devane CL, Chiao E, Franklin M, Kruep EJ (2005) Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. Am J Manag Care 11: S344-353.

Rajput M, Sinha S, Mathur V, Agrawal P (2011) Herbal antidepressants. International Journal of Pharmaceutical Frontier Research 1: 159-169

Benazzi F (2006) Various forms of depression. Dialogues. Clin Neurosci 8: 151-161.

Sansone R, Correll T (2005) Dysthymic disorder: The persistent depression. Psychiatry 9: 1-2

Baghai T, Binder E, Schule C, Salyakina D, Eser D, et al. (2008) Effects of different antidepressant treatments on the core of depression. Dialogues in Clinical Neuroscience 10: 309-320.

Chaudron LH (2003) Post-partum depression: what pediatricians need to know. Pediatr Rev 24: 154-161.

Schatzberg AF (2003) New approaches to managing psychotic depression. J Clin Psychiatry 1: 19-23.

Swartz C, Shorter E (2007) Psychotic depression. Cambridge University Press, 32nd Avenue, New York, USA.

Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, et al. (2003) Psychotic depression and mortality. Am J Psychiatry 160: 574-576

Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:

World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.

Raman Deep Pattanayak , Rajesh Sagar a study on Depressive Disorders in Indian Context : A Review and Clinical Update for Physicians in the Journal of the association of physicians of india vol 62 published on 1st of every month 1st september, 2014.

Psychiatric University Hospital, University of Berne, on PATHOPHYSIOLOGY OF DEPRESSION: DO WE HAVE ANY SOLID EVIDENCE OF INTEREST TO

CLINICIANS in world psychiatry journal

Charles H. Brown, Pharmacotherapy of Major Depressive Disorder, Mental health published November 16, 2011.

Bérard A, Zhao JP and Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ. 2016; DOI;10.1136/bmjopen-2016-013372

Regina C. Casper, Barry E. Fleisher, Julie C. Lee-Ancajas, Allyson Gilles, Erika Gaylor,

Anne Debattista And H. Eugene Hoyme. Follow-up of children of depressed mothersexposed or not exposed to antidepressant drugs during pregnancy. Journal of pediatrics.

2003; 142: 402-8.

Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A., Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005; 365: 482-7.

Published

11-05-2022

How to Cite

Singh, P., & Geetha, P. (2022). Antidepressants exposure during gestation and their impact on the neurodevelopment and physical outcomes in the off spring. International Journal of Health Sciences, 6(S3), 5656–5664. https://doi.org/10.53730/ijhs.v6nS3.7209

Issue

Section

Peer Review Articles